1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > United States - Molecular Diagnostics Market, Test Volume and Company Analysis to 2020

The molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. The United States is the key market for molecular diagnostics due to the availability of government funds, rising incidence of chronic diseases, the availability of different types of tests, and high awareness of pharmacogenomics/personalized medicine. Moreover, major companies have easy access to United States which makes the United States the largest and most significant market for suppliers.


United States Molecular Diagnostics Market and Test Volume - Application Segment Analysis: In United States molecular diagnostic market, infectious disease controls the maximum share of the market. Molecular oncology tests have emerged as a significant rapidly growing market segment. Increased public awareness of the relationship between genetics and personal health has increased the demand for molecular genetic testing. The genetic testing is the third leading segment of the molecular diagnostics market followed by the blood screening test market. Molecular diagnostics is also gaining popularity as an important tool for HLA Testing, Food Pathogen Detection Testing and other disease areas.


United States is the major food safety testing market. The food pathogen test volume accounts for the maximum share of the molecular diagnostics volume. The infectious disease at the second spot in molecular diagnostics application test volume with nearly XX% volume share in 2014. The oncology testing stands at the third spot in molecular diagnostics test volume followed by the blood screening test. Genetic testing and HLA tests are also gaining popularity in the molecular diagnostics landscape.




United States Molecular Diagnostics Market - Company Analysis: In the United States molecular diagnostics market, Hologic Inc. captures the maximum share of the market. Myriad Genetics holds the second position in the United States molecular diagnostics market being followed by Roche. In 2014, Molecular Diagnostics accounted for 50% of Qiagen total sales. In 2015, Cepheid is anticipated to extend the market segment reach with entry into the CLIA-waived testing market in the US.

iGATE RESEARCH report titled “United States - Molecular Diagnostics Market, Test Volume and Company Analysis to 2020” is a 130 page report with 87 Figures. This report studies in detail the United States Molecular Diagnostics Market and Test Volume, United States Molecular Diagnostics Company Sales Analysis along with the Driving Factors and Challenges for the United States Molecular Diagnostics Market.

The United States Molecular Diagnostics Market has been analysed from 4 View Points:

1) United States - Molecular Diagnostics Market and Forecast
2) United States Molecular Diagnostics Market - Application Segment Analysis
3) United States Molecular Diagnostics Market - Application Segment Test Volume Analysis
4) United States Molecular Diagnostics Market - Company Sales Analysis

United States Molecular Diagnostics Market and Test Volume - Application Segment Analysis (2010 - 2020)

1. Oncology Testing
a) Breast Cancer
b) Colorectal Cancer
c) Prostate Cancer
d) Others

2. Infectious Diseases
a) Virology Testing
b) HPV Testing
c) HAI Testing
d) Critical Care Testing

3. Genetic Testing
4. Blood Screening
5. Food Pathogen Testing
6. Tissue Typing (HLA Testing)


United States Molecular Diagnostics - Company Sales Analysis (2010 - 2020)

1. Roche
2. Abbott
3. Myriad Genetics
4. BioMerieux
5. Qiagen
6. Hologic Inc.
7. Becton Dickinson
8. Siemens
9. Cepheid
10. Others


Source of Information


iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government And NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries And Local Councils and a large number of Paid Databases.

Table Of Contents

United States - Molecular Diagnostics Market, Test Volume and Company Analysis to 2020
1. Executive Summary
2. United States - Molecular Diagnostics Market, Test Volume and Forecast (2010 - 2020)
2.1 United States - Molecular Diagnostics Market and Forecast
2.2 United States - Molecular Diagnostics Test Volume and Forecast
3. United States - Molecular Diagnostics Market and Volume Share (2010 - 2020)
3.1 United States - Application Wise Molecular Diagnostics Market Share and Forecast
3.2 United States - Company Wise Molecular Diagnostics Market Share and Forecast
3.3 United States Molecular Diagnostics Test Volume Share and Forecast - Application Wise
4. United States Molecular Diagnostics Market and Forecast - Application Wise
4.1 Oncology Testing Market (2004 - 2020)
4.1.1 Breast Cancer Testing Market (2004 - 2020)
4.1.2 Colorectal Cancer Testing Market (2004 - 2020)
4.1.3 Prostate Cancer Testing Market (2004 - 2020)
4.1.4 Other Cancer Testing Market (2004 - 2020)
4.2 Infectious Disease Testing Market (2010 - 2020)
4.2.1 Virology Testing Market (2007 - 2020)
4.2.2 HPV Testing Market (2004 - 2020)
4.2.3 HAI Testing Market (2010 - 2020)
4.2.4 Critical Care Testing Market (2010 - 2020)
4.3 Genetic Testing Market (2010 - 2020)
4.4 Blood Screening Market (2006 - 2020)
4.5 Food Pathogen Testing Market (2010 - 2020)
4.6 Tissue Typing (HLA) Testing Market (2008 - 2020)
5. United States Molecular Diagnostics Test Volume - Application Wise
5.1 Oncology Test Volume (2004 - 2020)
5.1.1 Breast Cancer Test Volume (2004 - 2020)
5.1.2 Colorectal Cancer Test Volume (2004 - 2020)
5.1.3 Prostate Cancer Test Volume (2004 - 2020)
5.1.4 Other Cancer Test Volume (2004 - 2020)
5.2 Infectious Disease Test Volume (2010 - 2020)
5.2.1 Virology Test Volume (2007 - 2020)
5.2.2 HPV Test Volume (2004 - 2020)
5.2.3 HAI Test Volume (2010 - 2020)
5.2.4 Critical Care Test Volume (2010 - 2020)
5.3 Genetic Testing Test Volume and Forecast (2010 - 2020)
5.4 Blood Screening Test Volume and Forecast (2006 - 2020)
5.5 Food Pathogen Test Volume and Forecast (2010 - 2020)
5.6 HLA Test Volume and Forecast (2008 - 2020)
6. United States Molecular Diagnostics Market - Company Wise
6.1 Roche - United States Molecular Diagnostic Sales and Forecast
6.2 Abbott Laboratories - United States Molecular Diagnostic Sales and Forecast
6.3 Myriad Genetics - United States Molecular Diagnostic Sales and Forecast
6.4 Biomerieux - United States Molecular Diagnostic Sales and Forecast
6.5 Qiagen - United States Molecular Diagnostic Sales and Forecast
6.6 Hologic Inc. (Acquired Gen-Probe) - United States Molecular Diagnostic Sales and Forecast
6.7 Becton Dickinson - United States Molecular Diagnostic Sales and Forecast
6.8 Siemens - United States Molecular Diagnostic Sales and Forecast
6.9 Cepheid - United States Molecular Diagnostic Sales and Forecast
6.10 Others - United States Molecular Diagnostic Sales and Forecast
7. United States Molecular Diagnostics Market - Driving Factors
7.1 Increasing Automation to Drive the Molecular Diagnostics Market
7.2 Investment in Genomics and Proteomics Research
7.3 Personalized Medicine Fuels Molecular Diagnostics
8. United States Molecular Diagnostics Market - Challenges
8.1 Regulatory Issues
8.2 Reimbursement Capabilities
8.3 Quality Checkpoints, Awareness and Acceptance

List of Figures:

Figure 2-1: United States - Molecular Diagnostics Market (Million US$), 2010 - 2014
Figure 2-2: United States - Forecast for Molecular Diagnostics Market (Million US$), 2015 - 2020
Figure 2-3: United States - Molecular Diagnostics Test Volume (Million), 2010 - 2014
Figure 2-4: United States - Forecast for Molecular Diagnostics Test Volume (Million), 2015 - 2020
Figure 3-1: United States - Molecular Diagnostics Applications Market Share (Percent), 2010 - 2014
Figure 3-2: United States - Forecast for Molecular Diagnostics Applications Market Share (Percent), 2015 - 2020
Figure 3-3: United States - Company Wise Molecular Diagnostics Market Share (Percent), 2010 - 2014
Figure 3-4: United States - Forecast for Company Wise Molecular Diagnostics Market Share (Percent), 2015 - 2020
Figure 3-5: United States - Molecular Diagnostics Applications Test Volume Share (Percent), 2010 - 2014
Figure 3-6: United States - Forecast for Molecular Diagnostics Applications Test Volume Share (Percent), 2015 - 2020
Figure 4-1: United States - Molecular Diagnostic Oncology Testing Market (Million US$), 2004 - 2014
Figure 4-2: United States - Forecast for Molecular Diagnostic Oncology Testing Market (Million US$), 2015 - 2020
Figure 4-3: United States - Molecular Diagnostic Breast Cancer Testing Market (Million US$), 2004 - 2014
Figure 4-4: United States - Forecast for Molecular Diagnostic Breast Cancer Testing Market (Million US$), 2015 - 2020
Figure 4-5: United States - Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2004 - 2014
Figure 4-6: United States - Forecast for Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2015 - 2020
Figure 4-7: United States - Molecular Diagnostic Prostate Cancer Testing Market (Million US$), 2004 - 2014
Figure 4-8: United States - Forecast for Molecular Diagnostic Prostate Cancer Testing Market (Million US$), 2015 - 2020
Figure 4-9: United States - Other Molecular Diagnostic Cancer Testing Market (Million US$), 2004 - 2014
Figure 4-10: United States - Forecast for Other Molecular Diagnostic Cancer Testing Market (Million US$), 2015 - 2020
Figure 4-11: United States - Infectious Disease Testing Market (Million US$), 2010 - 2014
Figure 4-12: United States - Forecast for Infectious Disease Testing Market (Million US$), 2015 - 2020
Figure 4-13: United States - Virology Testing Market (Million US$), 2007 - 2014
Figure 4-14: United States - Forecast for Virology Testing Market (Million US$), 2015 - 2020
Figure 4-15: United States - HPV Testing Market (Million US$), 2004 - 2014
Figure 4-16: United States - Forecast for HPV Testing Market (Million US$), 2015 - 2020
Figure 4-17: United States - HAI Testing Market (Million US$), 2010 - 2014
Figure 4-18: United States - Forecast for HAI Testing Market (Million US$), 2015 - 2020
Figure 4-19: United States - Critical Care Testing Market (Million US$), 2010 - 2014
Figure 4-20: United States - Forecast for Critical Care Testing Market (Million US$), 2015 - 2020
Figure 4-21: United States - Genetic Testing Market (Million US$), 2010 - 2014
Figure 4-22: United States - Forecast for Genetic Testing Market (Million US$), 2015 - 2020
Figure 4-23: United States - Blood Screening Market (Million US$), 2006 - 2014
Figure 4-24: United States - Forecast for Blood Screening Market (Million US$), 2015 - 2020
Figure 4-25: United States - Food Pathogen Testing Market (Million US$), 2010 - 2014
Figure 4-26: United States - Forecast for Food Pathogen Testing Market (Million US$), 2015 - 2020
Figure 4-27: United States - HLA Testing Market (Million US$), 2008 - 2014
Figure 4-28: United States - Forecast for HLA Testing Market (Million US$), 2015 - 2020
Figure 5-1: United States - Oncology Test Volume (Million), 2004 - 2014
Figure 5-2: United States - Forecast for Oncology Test Volume (Million), 2015 - 2020
Figure 5-3: United States - Breast Cancer Test Volume (Million), 2004 - 2014
Figure 5-4: United States - Forecast for Breast Cancer Test Volume (Million), 2015 - 2020
Figure 5-5: United States - Colorectal Cancer Test Volume (Million), 2004 - 2014
Figure 5-6: United States - Forecast for Colorectal Cancer Test Volume (Million), 2015 - 2020
Figure 5-7: United States - Prostate Cancer Test Volume (Million), 2004 - 2014
Figure 5-8: United States - Forecast for Prostate Cancer Test Volume (Million), 2015 - 2020
Figure 5-9: United States - Other Cancer Test Volume (Million), 2004 - 2014
Figure 5-10: United States - Forecast for Other Cancer Test Volume (Million), 2015 - 2020
Figure 5-11: United States - Infectious Disease Test Volume (Million), 2010 - 2014
Figure 5-12: United States - Forecast for Infectious Disease Test Volume (Million), 2015 - 2020
Figure 5-13: United States - Virology Test Volume (Million), 2007 - 2014
Figure 5-14: United States - Forecast for Virology Test Volume (Million), 2015 - 2020
Figure 5-15: United States - HPV Test Volume (Million), 2004 - 2014
Figure 5-16: United States - Forecast for HPV Test Volume (Million), 2015 - 2020
Figure 5-17: United States - HAI Test Volume (Million), 2010 - 2014
Figure 5-18: United States - Forecast for HAI Test Volume (Million), 2015 - 2020
Figure 5-19: United States - Critical Care Test Volume (Million), 2010 - 2014
Figure 5-20: United States - Forecast for Critical Care Test Volume (Million), 2015 - 2020
Figure 5-21: United States - Genetic Testing Test Volume (Million), 2010 - 2014
Figure 5-22: United States - Forecast for Genetic Testing Test Volume (Million), 2015 - 2020
Figure 5-23: United States - Blood Screening Test Volume (Million), 2006 - 2014
Figure 5-24: United States - Forecast for Blood Screening Test Volume (Million), 2015 - 2020
Figure 5-25: United States - Food Pathogen Test Volume (Million), 2010 - 2014
Figure 5-26: United States - Forecast for Food Pathogen Test Volume (Million), 2015 - 2020
Figure 5-27: United States - HLA Test Volume (Million), 2008 - 2014
Figure 5-28: United States - Forecast for HLA Test Volume (Million), 2015 - 2020
Figure 6-1: Roche - United States Molecular Diagnostic Sales (Million US$), 2008 - 2014
Figure 6-2: Roche - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-3: Abbott Laboratories - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-4: Abbott Laboratories - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-5: Myriad Genetics - United States Molecular Diagnostic Sales (Million US$), 2007 - 2014
Figure 6-6: Myriad Genetics - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-7: Biomerieux - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-8: Biomerieux - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-9: Qiagen - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-10: Qiagen - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-11: Hologic-Gen-Probe - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-12: Hologic-Gen-Probe - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-13: Becton Dickinson - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-14: Becton Dickinson - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-15: Siemens - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-16: Siemens - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-17: Cepheid - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-18: Cepheid - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 6-19: Others - United States Molecular Diagnostic Sales (Million US$), 2010 - 2014
Figure 6-20: Others - Forecast for United States Molecular Diagnostic Sales (Million US$), 2015 - 2020
Figure 7-1: United States - Investment in the Human Genome Project (Billion US$), 2003, 2012

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

Life Science Instrumentation Market by Technology, End User, Application - Global Forecast to 2021

Life Science Instrumentation Market by Technology, End User, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global life science instrumentation market is estimated to grow at a CAGR of 6.8% from 2016 to 2021, to reach USD 64.52 billion by 2021. Factors such as increasing spending on pharmaceutical R&D, growing ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.